Abcam
Abcam plc, commonly known as Abcam, is a leading life sciences company headquartered in Cambridge, GB. Founded in 1998, Abcam has established itself as a prominent player in the biotechnology industry, specialising in the production and distribution of high-quality antibodies and related products. With a strong focus on research and development, the company serves a global market, with significant operations across Europe, North America, and Asia. Abcam's core offerings include a vast range of antibodies, proteins, and assays, which are renowned for their specificity and reliability. The company’s commitment to innovation and quality has positioned it as a trusted partner for researchers in academia and industry alike. Notable achievements include a robust portfolio of over one million products, making Abcam a go-to resource for scientists seeking advanced tools for their research.
DitchCarbon Score
How does Abcam's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Retail Trade Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Abcam's score of 47 is higher than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Abcam's reported carbon emissions
In 2022, Abcam reported total carbon emissions of approximately 102,263,000 kg CO2e, with significant contributions from Scope 3 emissions, which accounted for the entirety of this total. Scope 1 emissions were about 1,224,000 kg CO2e, and Scope 2 emissions were approximately 3,370,000 kg CO2e. The combined Scope 1 and 2 emissions totalled around 4,594,000 kg CO2e. Abcam has set ambitious climate commitments, aiming to reduce its Scope 1 and Scope 2 emissions to near zero by 2025. This near-term target reflects the company's commitment to significantly lower its direct and indirect emissions in the coming years. In 2021, the company reported total emissions of about 87,858,000 kg CO2e globally, with Scope 1 emissions at approximately 1,111,000 kg CO2e and Scope 2 emissions around 4,113,000 kg CO2e. The previous year's data from 2020 indicated total emissions of about 55,008,000 kg CO2e, with Scope 1 at approximately 1,554,000 kg CO2e and Scope 2 at around 3,198,000 kg CO2e. Abcam's ongoing efforts to address climate change demonstrate a proactive approach to sustainability within the life sciences sector, aligning with industry standards for carbon reduction and climate responsibility.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | |
|---|---|---|---|
| Scope 1 | 1,554,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 3,198,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 50,256,000 | 00,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Abcam is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
